We are live on
!
Find out more
A
AustralianSuper Portfolio holdings
AUM
$23.1B
1-Year Est. Return
49.74%
This Fund
S&P 500
This Quarter
Est. Return
-6.68%
1 Year Est. Return
+49.74%
3 Year Est. Return
+142.09%
5 Year Est. Return
+159.34%
10 Year Est. Return
–
AUM
$14.1B
AUM Growth
-$2.16B
(-13%)
Cap. Flow
-$1.37B
Cap. Flow
% of AUM
-9.72%
Top 10 Holdings %
Top 10 Hldgs %
36.18%
Holding
188
New
13
Increased
68
Reduced
72
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$112M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$104M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$84.1M |
| 4 |
Johnson & Johnson
JNJ
|
+$74.7M |
| 5 |
Medtronic
MDT
|
+$71.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$511M |
| 2 |
Apple
AAPL
|
+$151M |
| 3 |
Advanced Micro Devices
AMD
|
+$110M |
| 4 |
Adobe
ADBE
|
+$105M |
| 5 |
Illumina
ILMN
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.83% |
| 2 | Technology | 17.26% |
| 3 | Financials | 15.52% |
| 4 | Materials | 13.26% |
| 5 | Consumer Discretionary | 10.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
TSMC
TSM
$2.16T
| $177M | 1.26% |
2,581,789
+30,216
| +1% | +$2.5M |
|
27
Icon
ICLR
$12.6B
| $168M | 1.19% |
912,797
+6,345
| +0.7% | +$1.38M |
|
28
Bio-Rad Laboratories Class A
BIO
$10.4B
| $164M | 1.17% |
392,994
+5,427
| +1% | +$2.71M |
|
29
Toronto Dominion Bank
TD
$202B
| $159M | 1.13% |
2,592,951
-510,193
| -16% | -$33M |
|
|
30
Johnson & Johnson
JNJ
$671B
| $154M | 1.1% |
942,268
+441,432
| +88% | +$74.7M |
|
|
EA
31
DELISTED
Electronic Arts
EA
| $142M | 1.01% |
1,224,536
-2,004
| -0.2% | -$253K |
|
|
ANSS
32
DELISTED
Ansys
ANSS
| $115M | 0.82% |
520,534
+6,245
| +1% | +$1.6M |
|
33
O'Reilly Automotive
ORLY
$70.7B
| $112M | 0.8% |
2,396,385
-243,615
| -9% | -$11.4M |
|
34
Match Group
MTCH
$9.74B
| $110M | 0.78% |
2,294,239
+193,667
| +9% | +$12.2M |
|
35
ServiceNow
NOW
$151B
| $108M | 0.77% |
1,425,495
-680,300
| -32% | -$61.3M |
|
36
Alphabet (Google) Class C
GOOG
$4.15T
| $107M | 0.76% |
1,110,000
-827,000
| -43% | -$92.3M |
|
|
37
Pfizer
PFE
$164B
| $101M | 0.72% |
+2,299,469
| New | +$112M |
|
38
Coca-Cola
KO
$382B
| $100M | 0.71% |
1,791,223
+792,029
| +79% | +$49.2M |
|
39
AutoZone
AZO
$48.5B
| $97.7M | 0.7% |
45,618
+9,858
| +28% | +$21.5M |
|
40
Regeneron Pharmaceuticals
REGN
$86.8B
| $90.2M | 0.64% |
130,969
+66,692
| +104% | +$42M |
|
|
SCHW
41
Charles Schwab
SCHW
$191B
| $87M | 0.62% |
+1,211,064
| New | +$84.1M |
|
42
Accenture
ACN
$118B
| $84.4M | 0.6% |
327,947
-23,688
| -7% | -$6.85M |
|
43
Moderna
MRNA
$59.4B
| $84.3M | 0.6% |
712,575
+68,855
| +11% | +$10.4M |
|
44
Bristol-Myers Squibb
BMY
$139B
| $82.6M | 0.59% |
1,161,418
-397,929
| -26% | -$28.9M |
|
45
VeriSign
VRSN
$26.5B
| $81.4M | 0.58% |
468,660
+80,911
| +21% | +$15M |
|
46
General Motors
GM
$76.5B
| $80.9M | 0.58% |
2,522,081
-1,213,638
| -32% | -$44.5M |
|
47
Qualcomm
QCOM
$180B
| $76M | 0.54% |
672,974
-55,781
| -8% | -$7.66M |
|
48
Automatic Data Processing
ADP
$113B
| $75.3M | 0.54% |
332,746
+143,596
| +76% | +$33.9M |
|
49
Manulife Financial
MFC
$73.9B
| $72.9M | 0.52% |
4,650,743
+1,300,000
| +39% | +$22.8M |
|
50
Nike
NKE
$57.5B
| $72.7M | 0.52% |
875,199
+266,731
| +44% | +$28.7M |
|
Similar funds
CLGM
DSA
BBHC
CB
EIM
AustralianSuper's Q3 2022 Portfolio in Review
As of Q3 2022, AustralianSuper held 188 positions worth $14.1B, down 13% from $16.2B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
AustralianSuper withdrew a net $1.37B in Q3 2022, closing 33 positions and reducing 72 holdings. Its most notable exit was Apple, an estimated $151M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Technology and Financials.
Against the trend, AustralianSuper opened a new position in Pfizer worth $101M.
- AustralianSuper's largest Q3 2022 buy was Pfizer: 2,299,469 shares worth $101M.
- AustralianSuper added most to Thermo Fisher Scientific in Q3 2022, an estimated $104M increase.
- AustralianSuper's biggest Q3 2022 reduction was Amazon, cutting an estimated $511M.
- AustralianSuper fully exited Apple in Q3 2022, selling an estimated $151M.
- AustralianSuper's ten largest holdings make up 36% of its $14.1B portfolio in Q3 2022.
- AustralianSuper opened 13 new positions and closed 33 in Q3 2022.
- AustralianSuper's portfolio value fell 13% quarter-over-quarter to $14.1B.
Based on AustralianSuper's 13F filing for Q3 2022, filed 14 Nov 2022.